Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Himmelfarb

Showing results (111-120 of 370) with videos related to

Pageof 37
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 4, 2016
Markers of kidney disease and risk of subclinical and clinical heart failure in African Americans: the Jackson Heart StudyNisha Bansal, Ronit Katz, Jonathan Himmelfarb, et al.
Kidney International|August 13, 2003
Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal diseaseJonathan Himmelfarb, Jane Kane, Ellen McMonagle, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 17, 2026
Potential integration of multiple organs-on-a-chip for comprehensive drug-drug interaction predictionEric W Hsu, Kai Wang, Yik Pui Tsang, et al.
Physiological Reports|May 6, 2014
Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney diseaseMaryam Afkarian, Irl B Hirsch, Katherine R Tuttle, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapyMichael Danielski, T Alp Ikizler, Ellen McMonagle, et al.
Journal of the American Society of Nephrology : JASN|December 6, 2014
Evaluating risk of ESRD in the urban poorMarlena Maziarz, R Anthony Black, Christine T Fong, et al.
Expert Opinion on Drug Safety|June 26, 2025
Enhancing therapeutic strategies and drug development for patients with kidney diseaseYik Pui Tsang, Kayenat S Aryeh, Kai Wang, et al.
Seminars in Dialysis|September 30, 2005
What is the current and future status of interventional nephrology?Gerald A Beathard, Scott O Trerotola, Thomas M Vesely, et al.
Journal of Diabetes and Its Complications|September 29, 2015
Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetesMaryam Afkarian, Leila R Zelnick, John Ruzinski, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 19, 2014
Changes in symptom burden and physical performance with initiation of dialysis in patients with chronic kidney diseaseMatthew B Rivara, Cassianne Robinson-Cohen, Bryan Kestenbaum, et al.
Pageof 37

Showing results (111-120 of 370) with videos related to

Sort By:
Pageof 37
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 4, 2016
Markers of kidney disease and risk of subclinical and clinical heart failure in African Americans: the Jackson Heart StudyNisha Bansal, Ronit Katz, Jonathan Himmelfarb, et al.
Kidney International|August 13, 2003
Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal diseaseJonathan Himmelfarb, Jane Kane, Ellen McMonagle, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 17, 2026
Potential integration of multiple organs-on-a-chip for comprehensive drug-drug interaction predictionEric W Hsu, Kai Wang, Yik Pui Tsang, et al.
Physiological Reports|May 6, 2014
Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney diseaseMaryam Afkarian, Irl B Hirsch, Katherine R Tuttle, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 6, 2003
Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapyMichael Danielski, T Alp Ikizler, Ellen McMonagle, et al.
Journal of the American Society of Nephrology : JASN|December 6, 2014
Evaluating risk of ESRD in the urban poorMarlena Maziarz, R Anthony Black, Christine T Fong, et al.
Expert Opinion on Drug Safety|June 26, 2025
Enhancing therapeutic strategies and drug development for patients with kidney diseaseYik Pui Tsang, Kayenat S Aryeh, Kai Wang, et al.
Seminars in Dialysis|September 30, 2005
What is the current and future status of interventional nephrology?Gerald A Beathard, Scott O Trerotola, Thomas M Vesely, et al.
Journal of Diabetes and Its Complications|September 29, 2015
Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetesMaryam Afkarian, Leila R Zelnick, John Ruzinski, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 19, 2014
Changes in symptom burden and physical performance with initiation of dialysis in patients with chronic kidney diseaseMatthew B Rivara, Cassianne Robinson-Cohen, Bryan Kestenbaum, et al.
Pageof 37